Search Results
Aug 17, 2026, 14:36 ET FouAnalytics Announces Global Availability of FouAnalytics for Publishers, Decisioning Container
because legacy brand safety and fraud-verification vendors reported 1% invalid-traffic (IVT) rates across everything. While legitimate publishers actually had low IVT, fraudulent sellers' low IVT numbers were due to the failure of legacy verification vendors to detect not just bot traffic, but
More news about: FouAnalytics
Aug 07, 2026, 10:11 ET /C O R R E C T I O N -- FouAnalytics/
said.FouAnalytics Unlimited is designed for advertisers who will no longer accept vague dashboards, generic assurances and invalid traffic, or IVT, numbers that legacy vendors cannot explain. They want independent, forensic proof of where every dollar and every ad impression go, and they want it
More news about: FouAnalytics
Jul 31, 2026, 07:00 ET Ractigen Therapeutics Announces U.S. FDA IND Clearance for First-in-Class saRNA Candidate RAG-1C to Treat Proliferative Vitreoretinopathy
effectively inhibiting cellular proliferation and myofibroblast transformation without cellular toxicity. Administered as an intravitreal injection (IVT), RAG-1C offers the potential for long-lasting anti-fibrotic protection through a single intraoperative administration ("One-and-Done")."Securing
More news about: Ractigen Therapeutics
Jul 28, 2026, 08:57 ET TAG/ANA/ Fiducia Analysis Quantifies Level of "AI Slop" in Digital Advertising Supply Chain for First Time
ANA. Surprisingly, the analysis found that AI Slop outperformed clean inventory on conventional quality metrics, as AI Slop had an invalid traffic (IVT) rate of just 0.05% versus 0.32% for clean supply, it had higher viewability (77.2% versus 74.9%), and, after measurability was factored in, it graded
More news about: Trustworthy Accountability Group
Jul 14, 2026, 08:30 ET Business Outcomes Are Just the Beginning, According to IAB Digital Video Ad Spend & Strategy Full Report
Content Strategy, IAB. "Buyers are wondering 'where is my ad actually running, where does the inventory come from, and how much of it is invalid traffic (IVT).'"While fraud is the leading driver of mistrust, buyers are not willing to pay a premium to prevent it. Sellers should take action
More news about: Interactive Advertising Bureau (IAB)
Jun 08, 2026, 10:01 ET Pneumonia Market Set to Witness Robust Growth During the Forecast Period (2026-2036), Driven by Advancing Therapeutics and Rising Disease Burden | DelveInsight
(AR-301) (Aridis Pharmaceuticals), AON-D21 (Aptarion Biotech), Trimodulin (BT588) (Biotest AG), VAX-24 and VAX-31 (Vaxcyte, Inc.), PCV24 (CanSinoBIO), IVT PCV-25 (Inventprise), and others will further propel the market forward.LAS VEGAS, June
More news about: DelveInsight Business Research, LLP
Jun 05, 2026, 19:25 ET Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
InvenTrust PropertiesIVTReal Estate
More news about: S&P Dow Jones Indices
May 26, 2026, 08:20 ET Anura Publishes New Guide to Help Marketers Understand Invalid Traffic
better understand the problem and take practical steps to improve traffic quality."The eBook covers:What invalid traffic (IVT) is and why it mattersThe difference between General Invalid Traffic (GIVT) and Sophisticated Invalid Traffic (SIVT)How invalid traffic
More news about: Anura Solutions
May 17, 2026, 21:13 ET El Día de la Innovación de ACROBiosystems llega a Zúrich
la reutilización de las enzimas. Presentaron dos estudios de caso: la inmovilización de la ARN polimerasa T7 para sistemas de transcripción in vitro (IVT) semicontinuos, demostrando la retención de la actividad y el potencial de reutilización; y la inmovilización de la sortasa para la producción de conjugados
More news about: ACROBiosystems Group
May 17, 2026, 21:12 ET ACROBiosystems Innovation Day in Zürich bringt führende Köpfe zur Erkundung neuer Biotech-Grenzen zusammen
Enzymen erhöht. Sie stellten zwei Fallstudien vor: die Immobilisierung von T7-RNA-Polymerase für halbkontinuierliche In-vitro-Transkriptionssysteme (IVT), bei denen Aktivität und Wiederverwendbarkeit erhalten blieben, sowie die Immobilisierung von Sortase für die Herstellung von Antikörper-Wirkstoff-Konjugaten
More news about: ACROBiosystems Group
May 17, 2026, 21:10 ET Zurich accueille la journée de l'innovation d'ACROBiosystems : les plus grands esprits s'unissent pour explorer les frontières de la biotechnologie
réutilisation des enzymes. Ils ont présenté deux études de cas : l'immobilisation de l'ARN polymérase T7 pour les systèmes de transcription in vitro (IVT) semi-continus, démontrant une activité conservée et un potentiel de réutilisation ; et l'immobilisation de la sortase pour la production de conjugués
More news about: ACROBiosystems Group
May 12, 2026, 03:04 ET ACROBiosystems Innovation Day Lands in Zurich: Top Minds Unite to Explore Biotech Frontiers
enhances enzyme stability and reusability. They presented two case studies: immobilizing T7 RNA polymerase for semi-continuous in vitro transcription (IVT) systems, demonstrating retained activity and reuse potential; and immobilizing sortase for antibody-drug conjugate (ADC) production, achieving conjugation
More news about: ACROBiosystems Group
Apr 30, 2026, 09:00 ET Astellas to Highlight New Findings for Geographic Atrophy at ARVO 2026 Annual Meeting
IZERVAY's impact on maintenance of driving eligibilityIZERVAY's mechanism of actionIZERVAY's pharmacokinetics and immunogenicity after IVT injectionFindings on treatment-seeking behavior of patients with GAInsights from an epidemiology study of Stargardt‑type macular
More news about: Astellas Pharma Inc.
Apr 09, 2026, 15:26 ET Powered Research at ARVO 2026
against classic endpoints. Methods Neovascularization was induced via an IVT dose of DL-AAA in one eye of 4–6-month-old Dutch Belted rabbits. Control rabbits received a single 1 mg IVT dose of aflibercept 2.5 weeks post-induction. FA imaging via OCT was conducted 2-3 days prior to
More news about: Powered Research, LLC
Apr 01, 2026, 14:25 ET PRESENTAMOS EL NUEVO KIA SELTOS DEL 2027: SU CAPACIDAD DE SUV GRANDE PONE EN ALERTA AL SEGMENTO DE LOS SUV PEQUEÑOS
segmento que ofrece tres opciones de motorización, comenzando con el motor de cuatro cilindros y 2.0 litros acoplado a la transmisión variable inteligente (IVT) de Kia. Para quienes buscan una aceleración ágil, el motor turboalimentado de cuatro cilindros y 1.6 litros desarrolla aproximadamente 190 caballos
More news about: Kia America
Apr 01, 2026, 09:25 ET INTRODUCING THE ALL-NEW 2027 KIA SELTOS: BIG-SUV CAPABILITY PUTS SMALL SUV SEGMENT ON NOTICE
the segment to offer three powertrain options starting with the 2.0-liter four-cylinder engine paired with Kia's Intelligent Variable Transmission (IVT). For those seeking lively pickup, the turbocharged 1.6-liter four-cylinder engine develops an estimated 190 horsepower with standard advanced Multi-Mode
More news about: Kia America
Apr 01, 2026, 08:41 ET Escalated.io Releases S8FTY, A Patent Pending Real-Time Invalid Traffic Filtration System For Brands and Publishers
problems for all players, including:Misappropriated traffic counts: When forecasting future traffic volumes for internal or sales purposes, IVT (invalid traffic) can cause numbers to be exaggerated.Inaccurate KPIs and outcomes: Resolving key metrics to an overinflated denominator
More news about: Escalated.io
Apr 01, 2026, 08:30 ET Xtalks Announces its Life Science Webinar Calendar for April 2026
ShiftsDRUG DISCOVERY & DEVELOPMENTApr 8 - Translational Imaging to Accelerate Cardiovascular Drug DevelopmentApr 14 - Fast-Tracking IVT mRNA Candidate Selection Through Smarter RNA DesignApr 15 - Accelerating GLP-1 Peptides to Market Through Integrated Formulation
More news about: Xtalks
Mar 23, 2026, 08:30 ET Fast-Tracking IVT mRNA Candidate Selection Through Smarter RNA Design, Upcoming Webinar Hosted by Xtalks
Gain insight into how integrated in vitro transcribed (IVT) RNA and RNA-lipid nanoparticle (LNP) workflows can help move RNA discovery programs from construct design to actionable data with greater speed and confidence. Dr. Shambhavi Shubham will discuss parallel screening of RNA constructs
More news about: Xtalks
Mar 12, 2026, 03:01 ET GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub
site provides end-to-end mRNA workflow capabilities, including:Gene design and synthesisVector engineeringIVT mRNA productionProprietary GenCap™ mRNA capping technologyUTR optimization and formulation supportThe facility operates
More news about: GenScript Biotech Corporation
Mar 12, 2026, 02:49 ET GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub
site provides end-to-end mRNA workflow capabilities, including:Gene design and synthesisVector engineeringIVT mRNA productionProprietary GenCap™ mRNA capping technologyUTR optimization and formulation supportThe facility operates
More news about: GenScript Biotech Corporation
Jan 30, 2026, 08:00 ET BIGO Ads Enhances IAA Traffic Quality and Transparency Through Deepened Partnership with Pixalate
on the Rise: IAA Ecosystem Faces Growing Authenticity ThreatsAs the mobile advertising ecosystem continues to grow, invalid traffic (IVT) is becoming more sophisticated and harder to detect. Fraud tactics—ranging from app bundle spoofing to increasingly concealed automated
More news about: JOYY Inc.
Jan 27, 2026, 08:30 ET Anura Stops AI-Assisted SIVT Threat That Bypasses JavaScript-Based Fraud Detection Solutions
exploit vulnerabilities in JavaScript-based fraud detection solutions. This attack has proven capable of bypassing many IVT solutions that rely exclusively on client-side JavaScript, exposing a broader industry-wide risk.
More news about: Anura Solutions
Dec 23, 2025, 09:00 ET Brand & AI Safety Summit Series Expands to Dubai, Channel Factory Joins Launch as Initial Title Partner
and inspiring networking. The content highlights include: supporting youth safety online; AI's impact on the Brand Safety landscape; traffic quality, IVT, and traditional brand safety; creator economy and influencer marketing; and a refresh on brand suitability. That, and other sessions in the works, will
More news about: THE 614 GROUP
Dec 18, 2025, 13:54 ET KIA AMERICA ANUNCIA LOS PRECIOS DEL K4 HATCHBACK 2026
equipado de serie con un motor de 2.0 litros que genera 147 caballos de fuerza y 132 libras pie de torque, junto con una transmisión variable inteligente (IVT), mientras que el GT-Line Turbo incorpora un motor turboalimentado de 1.6 litros que entrega 190 caballos de fuerza y 195 libras pie de torque a las
More news about: Kia America